Company intelligence / Profile preview
May & Baker Nigeria
Ikeja, Lagos, Nigeria
- Ownership
- Private
- Employees
- ~396
- Development stage
- Other
01
Overview
May & Baker Nigeria is a leading Nigerian pharmaceutical manufacturer offering a variety of generic medicines, vaccines (in partnership), and consumer healthcare products. It produces and markets several essential medicines for infectious diseases, chronic conditions, and everyday health. Vaccine manufacturing through Biovaccines Nigeria is a key focus.
- Therapeutic areas
- EndocrinologyPsychiatryInfectious DiseasesCardiovascularNeurology
- Modalities
- Small moleculeVaccineBiologic
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Federal Government of Nigeria (Biovaccines Nigeria Limited)Sanofi (historical technical partner)
Beyond the preview
Go deeper on May & Baker Nigeria.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on May & Baker Nigeria.